FMR CORP 13D and 13G filings for Astria Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-12 08:46 am Sale |
2024-12-31 | 13G | Astria Therapeutics, Inc. ATXS |
FMR CORP | 7,823,729 13.900% |
-639,949 (-7.56%) |
Filing |
| 2024-11-12 09:50 am Purchase |
2024-11-08 | 13G | Astria Therapeutics, Inc. ATXS |
FMR CORP | 8,463,678 14.999% |
1,767,714 (+26.40%) |
Filing |
| 2024-07-10 10:10 am Purchase |
2024-07-09 | 13G | Astria Therapeutics, Inc. ATXS |
FMR CORP | 6,695,964 12.193% |
1,732,228 (+34.90%) |
Filing |
| 2024-03-11 08:19 am Sale |
2024-03-08 | 13G | Astria Therapeutics, Inc. ATXS |
FMR CORP | 4,963,736 9.080% |
-480,692 (-8.83%) |
Filing |
| 2024-02-09 08:35 am Purchase |
2024-02-08 | 13G | Astria Therapeutics, Inc. ATXS |
FMR CORP | 5,444,428 14.999% |
2,092,124 (+62.41%) |
Filing |
| 2023-01-10 12:48 pm Purchase |
2023-01-09 | 13G | Astria Therapeutics, Inc. ATXS |
FMR CORP | 3,352,304 12.798% |
3,352,304 (New Position) |
Filing |